- SELLAS Life Sciences ( NASDAQ: SLS ) said Thursday it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock.
- Shares -32.3% at $2.50 after hours.
- All of the securities in the offering will be sold by SELLAS.
- Cantor Fitzgerald is acting as the sole book-running manager for the offering.
- Other pricing and offering terms were not disclosed.
- Seeking Alpha contributor Gunner Laine recently laid out a "STRONG BUY" case for SLS .
- Press Release .
For further details see:
SELLAS stock slides -32% after launching stock and warrants offering